GlassScriptPhysician profile
Warda Saarah Shamshad
NPI 1154842755
$3,012.84
in general payments reported to CMS, 2019-2025
8 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $113 · 2023: $228 · 2024: $1,037 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,530 · Food and Beverage: $826 · Education: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,530.41 |
| Food and Beverage | $826.40 |
| Education | $423.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,305.45 | 2025 | |
| Integra Lifesciences Corporation | $1,114.36 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $307.02 | 2023-2025 | Stravix Pl, Stravix, Collagenase Santyl |
| Paragon 28, INC. | $112.56 | 2022 | |
| Stryker Corporation | $95.56 | 2019 | |
| Medtronic, INC. | $33.35 | 2023 | Intellis Adaptivestim |
| Osiris Therapeutics INC. | $24.07 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.47 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warda Shamshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.